Medine.co.uk

Betamox 40 Mg Palatable Tablets

Revised: 31 July 2008

AN: 00090/2008

SUMMARY OF PRODUCT CHARACTERISTICS


1. Name of the veterinary medicinal product


Betamox 40mg Palatable Tablets


2. Qualitative and quantitative composition


Each tablet contains :


Active Substance:

Amoxicillin 40 mg

(as Amoxicillin Trihydrate) 45.92 mg


Excipients:

For a full list of excipients, see section 6.1


3. Pharmaceutical form


Tablet

Off-white circular tablets scored on one face


4. Clinical Particulars


4.1 Target species


Dogs

Cats


4.2 Indications for use, specifying the target species


For use in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts and in the eye, ear, skin and wound infections caused by susceptible organisms. In vitro, amoxicillin is effective against a range of Gram-positive and Gram-negative bacteria, including:


Bacillus cereus

Bordetella bronchiseptica

Corynebacteriumspp

Chromobacterspp

Citrobacter freundii

Escherichia coli

Flavobacterspp

Proteus mirabilis

Pasteurella sppincluding Pasteurella multocida

Salmonellaspp

Staphylococci (penicillin sensitive strains)

Streptococci

4.3 Contraindications


Do not use in known cases of hypersensitivity to amoxicillin.

Not for administration to rabbits, guinea pigs, hamsters or gerbils.

Caution is advised when used in other small herbivores.


4.4 Special Warnings for each target species


No special warnings.

4.5 Special precautions for use


Special precautions for use in animals

None

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.


1. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.

2. Handle this product with great care to avoid exposure, taking all recommended precautions.

3. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.


Wash hands after use


4.6 Adverse reactions (frequency and seriousness)


No known undesirable effects.


4.7 Use during pregnancy, lactation or lay


No known contraindication exists for use of during pregnancy.


4.8 Interaction with other medicinal products and other forms of interaction


None known


4.9 Amounts to be administered and administration route


The recommended dose rate is 10 mg amoxicillin per kg bodyweight (one tablet per 4kg bodyweight) twice daily for 7 days.


Tablets are given orally by hand or crushed in food.


Any remaining medicated feed should be disposed of at the end of the day.


Overdose (symptoms, emergency procedures, antidotes), if necessary


Penicillins have a remarkably good safety record and overdose is highly unlikely.


Withdrawal period


Not applicable


5. pharmacological properties


Pharmacotherapeutic group: Antibiotic


ATC Vet Code: QJ01CA04


5.1 Pharmacodynamic properties


Amoxicillin is a broad-spectrum semi-synthetic penicillin. Amoxicillin predominately inhibits cell wall synthesis in susceptible bacteria. Amoxicillin has a mode of action which directly and irreversibly disrupts cell wall peptidoglycan. Amoxicillin is well absorbed following oral administration.


6. Pharmaceutical particulars


6.1 List of excipients


Cellulose Microcrystalline

Lactose Monohydrate

Sodium Starch Glycollate

Povidone K17

Yeast Dried (spray dried)

Magnesium Stearate


6.2 Incompatibilities


None known


Shelf-life


Shelf life of the veterinary medicinal product as packaged for sale: 2 years


Special precautions for storage


Do not store above 25ÂșC. Store in a dry place.


Nature and composition of immediate packaging


Betamox 40mg Palatable Tablets are supplied in white opaque high density polypropylene tubs with white opaque tamper evident, push-fit low density polyethylene caps of the following sizes:


100 x Betamox 40 mg Tablets

500 x Betamox 40 mg Tablets


Not all pack sizes may be marketed


Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


7. MARKETING AUTHORISATION HOLDER


Norbrook Laboratories Limited

Station Works

Newry

Co. Down, BT35 6JP

Northern Ireland


8. MARKETING AUTHORISATION NUMBER(S)


Vm 02000/4087


9. DATE OF FIRST AUTHORISATION

22ndSeptember 1987


10. DATE OF REVISION OF THE TEXT


July 2008